Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 8, Number 11—November 2002


Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family

Francis Drobniewski*Comments to Author , Yanina Balabanova*, Michael Ruddy*, Laura Weldon*, Katya Jeltkova†, Timothy Brown*, Nadezdna Malomanova‡, Elvira Elizarova‡, Alexander Melentyey§, Ebgeny Mutovkin§, Svetlana Zhakharova‡, and Ivan Fedorin‡
Author affiliations: *Guy's King's and St Thomas' Medical School, King's College Hospital, London, United Kingdom; †Central Tuberculosis Research Institute, Moscow, Russian Federation; ‡Samara Oblast Dispensary, Samara City, Russian Federation; §Samara Prison TB Service, Samara City, Russian Federation;

Main Article

Table 2

Patient factors associated with rifampin- and isoniazid-resistant isolatesa

Factor Rifampin resistance (n=78) Isoniazid resistance (n=66)
Age p<0.05b p>0.05
Known prisoner RR 1.68,b CI 1.29 to 2.18 RR 1.36, CI 0.97 to 1.89
Known previous treatment RR 1.71,b CI 1.07 to 2.74 RR=2.04,b CI 1.01 to 4.10

aRR, risk ratio; CI, confidence interval.
bStatistically significant.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO